IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
STABILITY INDICATING UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DASATINIB IN PHARMACEUTICAL DOSAGE FORMS

Author: JAHNAVI BANDLA, S. GANAPATY
Abstract: The present work describes the stability indicating method development and validation for the determination of Dasatinib in pharmaceutical dosage form using Ultra Performance Liquid Chromatography with UV detection. The optimized chromatographic conditions used were Acquity UPLC HSS C18 (100mm × 2.1mm, 1.8µ) column, 0.1% Orthophosphoric acid and acetonitrile in the ratio (50:50%v/v) as mobile phase run on an isocratic mode at a flow rate of 0.2ml/min. The column oven temperature was maintained at room temperature. The detection wavelength was found to be 321nm.The developed method was validatedas per ICH guidelines and found to be specific, rugged and robust. A linear response was found in the concentration range of 12.5µg/ml to 75µg/ml with correlation coefficient of 0.999, indicating that the method obeys Beer’s law. The % recovery for Dasatinib was found to be 99.80% to 100.19% indicating the method was accurate. The % relative standard deviation was found to be 0.7 indicating the method was precise. The drug was found to be stable at stressed conditions and the net degradation was found to be within the limits. The developed method can be used for the quality control of Dasatinib in pharmaceutical dosage form
Keyword: Dasatinib, Stability Indicating, Method development, Validation, UPLC
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free